EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee

Jennifer Dent, Micaella Jorge, Nora Sobrevilla, Thomas S Uldrick, Innocent Adoubi, Jyoti Bajpai, Mauricio Burotto, Huwaida Bulhan, Gideon T Dosunmu, Lilian Ekpo, Satish Gopal, Manuel R Espinoza-Gutarra und 14 weitere

Journal for ImmunoTherapy of Cancer · 2025-06 · 13 (6) · e011258

DOI: 10.1136/jitc-2024-011258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 22.06.2025. Verfasst von Jennifer Dent und 25 weiteren Autor:innen. Beteiligte Einrichtung: BIO Ventures for Global Health, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Clinical Trials as Topic, Health Services Accessibility. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is rapidly on the rise as a cause of morbidity and mortality in low- and middle-income countries (LMICs). However, despite the increasing importance of immune checkpoint inhibitors (ICIs) as a pillar of cancer therapy, access in these settings lags well behind that in high-income countries (HICs). Increasing the evaluation of ICIs through local clinical trials and demonstration projects, and inclusion in multinational clinical trials is the first step to improving access. In particular, the epidemiology and clinical presentation of cancer in LMICs is often distinct from that in HICs, and the impact of immune checkpoint blockade in these settings is understudied. Moreover, unique patterns of comorbidities, environmental factors, genetic diversity, and paucity of supportive infrastructure may all impact the risk-benefit and outcomes of cancer immunotherapy treatment. Local clinical trials not only directly impact the strengthening of infrastructure but also provide local authorities with better insight into the health economic benefit of cancer immunotherapy, giving impetus to adoption and reimbursement efforts. More local, regional, and multinational collaborative efforts are needed to speed up the evaluation, access, and adoption of ICIs throughout the developing world.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsClinical Trials as TopicHealth Services AccessibilityHumansDeveloping Countries

Stichwörter der Autor:innen

EducationImmune Checkpoint InhibitorImmune related adverse event - irAEInfection

Autor:innen und Institutionen

  • BIO Ventures for Global Health, Seattle, Washington, USA.
  • Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • University Teaching Hospital of Treichville, Abidjan, Côte d'Ivoire.
  • Apollo Hospital Navi Mumbai and Maharashtra, Navi Mumbai, India.
  • Bradford Hill Clinical Research Center, Santiago, Chile.

Förderung

  • NCI NIH HHS

Zitieren

APA

Dent, J., Jorge, M., Sobrevilla, N., Uldrick, T. S., Adoubi, I., Bajpai, J., Burotto, M., Bulhan, H., Dosunmu, G. T., Ekpo, L., Gopal, S., Espinoza-Gutarra, M. R., Homian, N. M., Kingham, T. P., Mathias, C., Ngwa, W., Niyonzima, N., Nkegoum, B., Olopade, O. I., …, & Kaufman, D. R. (2025). Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee. Journal for ImmunoTherapy of Cancer, 13(6), e011258. https://doi.org/10.1136/jitc-2024-011258

Vancouver

Dent J, Jorge M, Sobrevilla N, Uldrick TS, Adoubi I, Bajpai J, et al. Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee. Journal for ImmunoTherapy of Cancer. 2025;13(6):e011258. doi:10.1136/jitc-2024-011258

BibTeX
@article{Dent2025,
  author = {Dent, Jennifer and Jorge, Micaella and Sobrevilla, Nora and Uldrick, Thomas S and Adoubi, Innocent and Bajpai, Jyoti and Burotto, Mauricio and Bulhan, Huwaida and Dosunmu, Gideon T and Ekpo, Lilian and Gopal, Satish and Espinoza-Gutarra, Manuel R and Homian, N'da Marcelin and Kingham, T Peter and Mathias, Clarissa and Ngwa, Wilfred and Niyonzima, Nixon and Nkegoum, Blaise and Olopade, Olufunmilayo I and Odeny, Thomas A and Posey, Avery D and Sahebjam, Solmaz and Switzer, Regina and Tarhini, Ahmad A and Vanderpuye, Verna and Kaufman, David R},
  title = {Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {6},
  pages = {e011258},
  doi = {10.1136/jitc-2024-011258}
}
Kostenlos starten →